We are excited to share our recent Nature review co-authored with @LarisaLabzin and @HendersonLab! @UQMedicine @TRI_info
Mechanisms of antibody-dependent enhancement of infectious disease | Nature Reviews Immunology
https://t.co/VXKe9x0A98
Impact of CFTR Modulation on Pseudomonas aeruginosa Infection in People With Cystic Fibrosis | The Journal of Infectious Diseases | Oxford Academic https://t.co/WybYHdZU0m
Congratulations to @EmmaLedger_1 on her first, first author publication of her PhD project! Thank you to all co-authors involved including @Goldberg_Emory lab! Thank you to @CFAustralia for your support of this project! @TRI_info#UQ
https://t.co/kUSnCu3dWJ
Congratulations Genevieve on graduating with first class Honours last week π You were a valued member of the lab and will be missed! Good luck with your medical studies next year!
Along with The Prince Charles Hospital lung transplant lab we were honoured to receive the Discovery and Innovation Research Award at the 2023 Metro North Research Excellence evening last night! π₯π§¬
Cloaking Antibodies Treatment @IMBatUQ @UQMedicine is a finalist in the AIDRC Eureka Prize for Infectious Diseases Research.
Learn more: https://t.co/EdqBtChSHE
#EurekaPrizes#FrazerInstUQ
First HDR talk of the #FrazerInstUQ Research Symposium is Emma Ledger presenting her work on the impact of CFTR modulation on P. aeruginosa infection in people with Cystic Fibrosis. @UQ_News@TRI_info
Our 3rd year PhD student, Emma Ledger presented her latest research last night on Pseudomonas aeruginosa infection post CFTR modulation in people with cystic fibrosis at ASM, Perth, 2023! @AUSSOCMIC Go swing by her poster tonight (#149) if you missed out #2023ASM